Open Access Email this article to a friend

The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts

Dušan Milanović*, Friederike Braun, Wolfgang Weber, Anca Ligia Grosu, Martin Behe and Gabriele Niedermann

BMC Cancer 2012, 12:242  doi:10.1186/1471-2407-12-242

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?